Are We Right to Consider Mesenchymal Stem Cells to Be a New Perspective for Patients with Juvenile Idiopathic Arthritis?
Crossref DOI link: https://doi.org/10.1007/s00005-017-0493-3
Published Online: 2017-10-13
Published Print: 2018-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Orczyk, Krzysztof
Smolewska, Elzbieta http://orcid.org/0000-0002-8421-0448
Funding for this research was provided by:
Uniwersytet Medyczny w Lodzi (502-03/8-000/01/502-64-094)
License valid from 2017-10-13